Ignite Creation Date:
2025-12-26 @ 5:18 PM
Ignite Modification Date:
2025-12-26 @ 5:18 PM
Study NCT ID:
NCT04862806
Status:
UNKNOWN
Last Update Posted:
2021-09-17
First Post:
2021-03-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL
Sponsor:
Bnai Zion Medical Center
Organization:
Study Overview
Official Title:
Safety, Efficacy and a Simple Model to Predict Response of BNT162b2 mRNA
Status:
UNKNOWN
Status Verified Date:
2021-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
On behalf of the Israel CLL study group the investigators will evaluate the efficacy and safety of BNT162b2 mRNA Covid-19 Vaccine in patients with chronic lymphocytic leukemia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: